Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Hepatic and cardiac and iron overload detected by T2* magnetic resonance (MRI) in patients with myelodisplastic syndrome: A cross-sectional study.

Mantovani LF, Santos FPS, Perini GF, Nascimento CMB, Silva LP, Wroclawski CK, Esposito BP, Ribeiro MSS, Velloso EDRP, Nomura CH, Kay FU, Baroni RH, Hamerschlak N, Schuster S.

Leuk Res. 2019 Jan;76:53-57. doi: 10.1016/j.leukres.2018.12.001. Epub 2018 Dec 4.

PMID:
30572266
2.

Real-life Outcomes on Acute Promyelocytic Leukemia in Brazil - Early Deaths Are Still a Problem.

Silva WFD Jr, Rosa LID, Marquez GL, Bassolli L, Tucunduva L, Silveira DRA, Buccheri V, Bendit I, Rego EM, Rocha V, Velloso EDRP.

Clin Lymphoma Myeloma Leuk. 2019 Feb;19(2):e116-e122. doi: 10.1016/j.clml.2018.11.004. Epub 2018 Nov 12.

PMID:
30509780
3.

Overall survival of Brazilian acute myeloid leukemia patients according to the European LeukemiaNet prognostic scoring system: a cross-sectional study.

Datoguia TS, Velloso EDRP, Helman R, Musacchio JG, Salvino MA, Soares RA, Higashi M, Fadel AV, E Silva RSA, Hamerschlak N, Santos FPS, Campregher PV.

Med Oncol. 2018 Sep 5;35(11):141. doi: 10.1007/s12032-018-1179-3.

PMID:
30187210
4.

Part 5: Myelodysplastic syndromes-Treatment of high-risk disease.

Magalhães SMM, Chauffaille MLLF, Velloso EDRP, Buzzini R, Bernardo WM.

Hematol Transfus Cell Ther. 2018 Jul-Sep;40(3):278-282. doi: 10.1016/j.htct.2018.05.013. Epub 2018 Jul 27. No abstract available.

5.

Part 4: Myelodysplastic syndromes-Treatment of low-risk patients with the 5q deletion.

Magalhães SMM, Velloso EDRP, Buzzini R, Bernardo WM.

Hematol Transfus Cell Ther. 2018 Jul-Sep;40(3):274-277. doi: 10.1016/j.htct.2018.05.012. Epub 2018 Jul 27. No abstract available.

6.

Part 3: Myelodysplastic syndromes-Treatment of low-risk patients without the 5q deletion.

Velloso EDRP, Magalhães SMM, Chauffaille MLLF, Buzzini R, Bernardo WM.

Hematol Transfus Cell Ther. 2018 Jul-Sep;40(3):267-273. doi: 10.1016/j.htct.2018.05.011. Epub 2018 Jul 27. No abstract available.

7.

Guidelines on myelodysplastic syndromes: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular.

Magalhães SMM, Niero-Melo L, Chauffaille MLLF, Velloso EDRP, Lorand-Metze I, Buzzini R, Bernardo WM.

Hematol Transfus Cell Ther. 2018 Jul-Sep;40(3):255-261. doi: 10.1016/j.htct.2018.05.004. Epub 2018 Jul 2. No abstract available.

8.

Deletion of RUNX1 exons 1 and 2 associated with familial platelet disorder with propensity to acute myeloid leukemia.

Cavalcante de Andrade Silva M, Krepischi ACV, Kulikowski LD, Zanardo EA, Nardinelli L, Leal AM, Costa SS, Muto NH, Rocha V, Velloso EDRP.

Cancer Genet. 2018 Apr;222-223:32-37. doi: 10.1016/j.cancergen.2018.01.002. Epub 2018 Feb 5.

PMID:
29666006
9.

Treating Adult Acute Lymphoblastic Leukemia in Brazil-Increased Early Mortality Using a German Multicenter Acute Lymphoblastic Leukemia-based regimen.

Fernandes da Silva Junior W, Medina AB, Yamakawa PE, Buccheri V, Velloso EDRP, Rocha V.

Clin Lymphoma Myeloma Leuk. 2018 Jun;18(6):e255-e259. doi: 10.1016/j.clml.2018.03.001. Epub 2018 Mar 14.

PMID:
29605423
10.

Molecular genetic techniques for gains and losses of genomic material in a case of acute myeloid leukemia.

Santos MFMD, Lara CC, Velloso EDRP.

Rev Bras Hematol Hemoter. 2017 Oct - Dec;39(4):385-387. doi: 10.1016/j.bjhh.2017.06.001. Epub 2017 Jul 20. No abstract available.

11.

Acute myeloid leukemia with e1a2 BCR-ABL1 fusion gene: two cases with peculiar molecular and clinical presentations.

da Silva FB, Machado-Neto JA, Koury LCA, Bertini VHLL, Ratis CA, Chauffaille MLLF, Velloso EDRP, Simões BP, Rego EM, Traina F.

Rev Bras Hematol Hemoter. 2017 Oct - Dec;39(4):379-384. doi: 10.1016/j.bjhh.2017.07.001. Epub 2017 Aug 3. No abstract available.

12.

Homozygous loss of function BRCA1 variant causing a Fanconi-anemia-like phenotype, a clinical report and review of previous patients.

Freire BL, Homma TK, Funari MFA, Lerario AM, Leal AM, Velloso EDRP, Malaquias AC, Jorge AAL.

Eur J Med Genet. 2018 Mar;61(3):130-133. doi: 10.1016/j.ejmg.2017.11.003. Epub 2017 Nov 10. Review.

PMID:
29133208
13.

Duffy null genotype or Fy(a-b-) phenotype are more accurate than self-declared race for diagnosing benign ethnic neutropenia in Brazilian population.

Dinardo CL, Kerbauy MN, Santos TC, Lima WM, Dezan MR, Oliveira VB, Mendrone-Júnior A, Rocha V, Velloso EDRP.

Int J Lab Hematol. 2017 Dec;39(6):e144-e146. doi: 10.1111/ijlh.12712. Epub 2017 Jul 10. No abstract available.

PMID:
28691206
14.

Identification of a novel fusion TBL1XR1-PDGFRB in a patient with acute myeloid leukemia harboring the DEK-NUP214 fusion and clinical response to dasatinib.

Campregher PV, Halley NDS, Vieira GA, Fernandes JF, Velloso EDRP, Ali S, Mughal T, Miller V, Mangueira CLP, Odone V, Hamerschlak N.

Leuk Lymphoma. 2017 Dec;58(12):2969-2972. doi: 10.1080/10428194.2017.1318437. Epub 2017 May 16. No abstract available.

PMID:
28509585
15.

Secondary myeloid neoplasms: bone marrow cytogenetic and histological features may be relevant to prognosis.

Tanizawa RS, Zerbini MC, Rosenfeld R, Kumeda CA, Azevedo RS, Siqueira SA, Velloso ED.

Rev Bras Hematol Hemoter. 2017 Jan - Mar;39(1):4-12. doi: 10.1016/j.bjhh.2016.09.015. Epub 2016 Dec 22.

16.

A Novel Assay for the Identification of NOTCH1 PEST Domain Mutations in Chronic Lymphocytic Leukemia.

Campregher PV, Petroni RC, Muto NH, Sitnik R, de Carvalho FP, Bacal NS, Velloso ED, Oliveira GB, Pinho JR, Torres DC, Mansur MB, Hassan R, Lorand-Metze IG, Chiattone CS, Hamerschlak N, Mangueira CL.

Biomed Res Int. 2016;2016:4247908. doi: 10.1155/2016/4247908. Epub 2016 Dec 15.

17.

Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.

da Silva FB, Machado-Neto JA, Bertini VHLL, Velloso EDRP, Ratis CA, Calado RT, Simões BP, Rego EM, Traina F.

J Clin Pathol. 2017 May;70(5):435-442. doi: 10.1136/jclinpath-2016-204023. Epub 2016 Nov 11.

PMID:
27836923
18.

Validation of interphase fluorescence in situ hybridization (iFISH) for multiple myeloma using CD138 positive cells.

Kishimoto RK, de Freitas SL, Ratis CA, Borri D, Sitnik R, Velloso ED.

Rev Bras Hematol Hemoter. 2016 Apr-Jun;38(2):113-20. doi: 10.1016/j.bjhh.2016.01.005. Epub 2016 Feb 23.

19.

Identification of ANLN as ETV6 partner gene in recurrent t(7;12)(p15;p13): a possible role of deregulated ANLN expression in leukemogenesis.

Campregher PV, Pereira WO, Lisboa B, Puga R, Helman R, Miyagi M, da Mata EH, Datoguia TS, Velloso ED, Bacal NS, Ross JS, Ali S, Miller V, Costa FF, Hamerschlak N, Santos FP.

Mol Cancer. 2015 Nov 19;14:197. doi: 10.1186/s12943-015-0471-5.

20.

Radiotherapy-related acute myeloid leukaemia with KMT2A amplification.

Fernandes CM, Hamerschlak N, Kishimoto RK, Ratis CA, Mangueira CL, Velloso ED.

Br J Haematol. 2016 Mar;172(5):653. doi: 10.1111/bjh.13822. Epub 2015 Oct 29. No abstract available.

PMID:
26514233
21.

Eosinophil chimerism in the differential diagnosis between DEK-NUP214-positive acute myeloid leukaemia relapse and chronic graft-versus-host disease.

e Moura de Souza CL, Bub CB, Torres MA, Velloso ED, Silveira PA, Correia RP, Bacal NS, Mangueira CL, Fernandes JF, Odone Filho V, Hamerschlak N, Campregher PV.

J Clin Pathol. 2015 Nov;68(11):950-2. doi: 10.1136/jclinpath-2015-203013. Epub 2015 Jul 20. No abstract available.

PMID:
26193901
22.

Possible benefit of consolidation therapy with high-dose cytarabine on overall survival of adults with non-promyelocytic acute myeloid leukemia.

Azevedo MC, Velloso ED, Buccheri V, Chamone DA, Dorlhiac-Llacer PE.

Braz J Med Biol Res. 2015 Feb;48(2):178-85. doi: 10.1590/1414-431X20144059. Epub 2014 Dec 12.

23.

Detection of cytogenetic abnormalities in mature B-cell neoplasms: the value of cultures with different mitogens.

da Silva Oliveira RM, Velloso ED.

Rev Bras Hematol Hemoter. 2014 Sep-Oct;36(5):379-80. doi: 10.1016/j.bjhh.2014.07.008. Epub 2014 Jul 18. No abstract available.

24.

Prognostic factors in adolescent and adult patients with acute lymphoblastic leukemia with two protocols of chemotherapy: a cross-sectional study.

Pinheiro Junior ED, Pracchia LF, Beitler de Mauriño B, Martinez GA, Dorlhiac-Llacer PE, Medina AB, Velloso ED.

Clin Lymphoma Myeloma Leuk. 2015 Jan;15(1):e7-e14. doi: 10.1016/j.clml.2014.07.006. Epub 2014 Jul 14.

PMID:
25130688
25.

Scientific comment on tumor suppressor p53 protein expression: prognostic significance in patients with low-risk myelodysplastic syndrome.

Velloso ED.

Rev Bras Hematol Hemoter. 2014 May-Jun;36(3):175-7. doi: 10.1016/j.bjhh.2014.03.009. Epub 2014 Apr 4. No abstract available.

26.

Metastatic melanoma mimicking acute leukaemia.

Kaliks RA, Silveira PA, Osawa A, Campregher PV, Bacal NS, Velloso ED.

Br J Haematol. 2014 Apr;165(1):1. doi: 10.1111/bjh.12669. Epub 2013 Nov 25. No abstract available.

PMID:
24266414
27.

Array-CGH as an adjuvant tool in cytogenetic diagnosis of pediatric MDS and JMML.

Silva AG, Maschietto M, Vidal DO, Peliçario LM, Velloso ED, Lopes LF, Krepischi AC, Rosenberg C.

Med Oncol. 2013 Dec;30(4):734. doi: 10.1007/s12032-013-0734-1. Epub 2013 Oct 2.

PMID:
24085545
28.

MDR-1 and GST polymorphisms are involved in myelodysplasia progression.

Palodetto B, de Melo Campos P, Benites BD, de Lourdes Lopes Ferrari Chauffaille M, Velloso ED, Traina F, Saad ST.

Leuk Res. 2013 Aug;37(8):970-3. doi: 10.1016/j.leukres.2013.04.024. Epub 2013 May 17.

29.

The detection of KIT mutations in acute myeloid leukemia.

Machado LE, Pinho JR, Sitnik R, Muto NH, Velloso ED, Petroni RC, Campregher PV.

Einstein (Sao Paulo). 2012 Jul-Sep;10(3):286-91. English, Portuguese.

30.

Cytogenetic studies of Brazilian pediatric myelodysplastic syndrome cases: challenges and difficulties in a large and emerging country.

Velloso ED, Chauffaille ML, Peliçario LM, Tanizawa RS, Toledo SR, Gaiolla RD, Lopes LF.

Braz J Med Biol Res. 2013 Jan;46(1):85-90. Epub 2013 Jan 11.

31.

Evaluation of chromosomal abnormalities by cIg-FISH and association with proliferative and apoptotic indexes in multiple myeloma.

Linardi CC, Martinez G, Velloso ED, Leal AM, Kumeda CA, Buccheri V, Azevedo RS, Peliçario LM, Dorlhiac-Llacer P.

Braz J Med Biol Res. 2012 Nov;45(11):1074-9. Epub 2012 Aug 23.

32.

Megakaryocyte.

Silveira PA, Velloso ED, Colombini MP, Guerra JC, Bacal NS, Bezerra AM, Pasqualin Dda C.

Einstein (Sao Paulo). 2011 Jun;9(2):247-8. doi: 10.1590/S1679-45082011AI2023. English, Portuguese. No abstract available.

33.

Molecular and cytogenetic abnormalities in acute myeloid leukemia: review and case studies.

Velloso ED, Motta CH, Furtado JB, Bacal NS, Silveira PA, Moyses CB, Sitnik R, Pinho JR.

Einstein (Sao Paulo). 2011 Jun;9(2):184-9. doi: 10.1590/S1679-45082011AO2041. English, Portuguese.

34.

Correlation between flow cytometry and histologic findings: ten year experience in the investigation of lymphoproliferative diseases.

Bezerra AM, Pasqualin Dda C, Guerra JC, Colombini MP, Velloso ED, Silveira PA, Mangueira CL, Kanayama RH, Nozawa ST, Correia R, Apelle AC, Pereira Wde O, Garcia RG, Bacal NS.

Einstein (Sao Paulo). 2011 Jun;9(2):151-9. doi: 10.1590/S1679-45082011AO2027. English, Portuguese.

35.

Early Detection of t(8;21) Chromosomal Translocations During Treatment of PML-RARA Positive Acute Promyelocytic Leukemia: A Case Study.

Neto WK, Serpa M, Sanabani SS, Bueno PT, Velloso ED, Dorlhiac-Llacer PE, Bendit I.

Clin Med Insights Oncol. 2010 Dec 20;4:163-70. doi: 10.4137/CMO.S6446.

36.

Karyotypic and fluorescent in situ hybridization study of the centromere of chromosome 7 in secondary myeloid neoplasms.

Tanizawa RS, Kumeda CA, de Azevedo Neto RS, Leal Ade M, Ferreira Pde B, Velloso ED.

Rev Bras Hematol Hemoter. 2011;33(6):425-31. doi: 10.5581/1516-8484.20110117.

37.

Incidence and risk factors of aplastic anemia in Latin American countries: the LATIN case-control study.

Maluf E, Hamerschlak N, Cavalcanti AB, Júnior AA, Eluf-Neto J, Falcão RP, Lorand-Metze IG, Goldenberg D, Santana CL, Rodrigues Dde O, Passos LN, Rosenfeld LG, Pitta M, Loggetto S, Ribeiro AA, Velloso ED, Kondo AT, Coelho EO, Pintão MC, de Souza HM, Borbolla JR, Pasquini R.

Haematologica. 2009 Sep;94(9):1220-6. doi: 10.3324/haematol.2008.002642.

38.

Lithium as a treatment of clozapine-induced neutropenia: a case report.

Brunoni AR, Kobuti Ferreira LR, Gallucci-Neto J, Elkis H, Velloso ED, Vinicius Zanetti M.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):2006-7. doi: 10.1016/j.pnpbp.2008.09.005. Epub 2008 Sep 12. No abstract available.

PMID:
18824055
39.

Aspergillary bronchopneumonia: an unusual cause of atelectasis and asphyxia in a leukemic patient.

Velloso ED, Martinez GA, Dorlhiac-Llacer PE, Chamone DA.

Sao Paulo Med J. 1994 Oct-Dec;112(4):639-41.

PMID:
7481428
40.

Long-term remission of neutropenia in Felty's syndrome after a short GM-CSF treatment.

Pereira J, Velloso ED, Loterio HA, Laurindo IM, Chamone DA.

Acta Haematol. 1994;92(3):154-6. Review.

PMID:
7871957
41.

Neutropenia associated with myelofibrosis in systemic lupus erythematosus.

Borba EF, Pereira RM, Velloso ED, Pereira IA, Goncalves CR, Yoshinari NH.

Acta Haematol. 1993;89(2):82-5.

PMID:
8503249
42.

[Benign systemic mastocytosis: report of 2 cases].

Velloso ED, Beitler B, Chamone DA.

Rev Hosp Clin Fac Med Sao Paulo. 1991 Mar-Apr;46(2):94-8. Portuguese.

PMID:
1843375
43.

[Psychological service for children under Social Security; activity of the Social Orientation Section for institutionalized children].

VELLOSO ED.

J Pediatr (Rio J). 1954 Aug-Sep;19(8-9):287-96. Portuguese. No abstract available.

PMID:
14366864

Supplemental Content

Loading ...
Support Center